Frequency Therapeutics Net Worth
Frequency Therapeutics Net Worth Breakdown | KRRO |
Frequency Therapeutics Net Worth Analysis
Frequency Therapeutics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Frequency Therapeutics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Frequency Therapeutics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Frequency Therapeutics' net worth analysis. One common approach is to calculate Frequency Therapeutics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Frequency Therapeutics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Frequency Therapeutics' net worth. This approach calculates the present value of Frequency Therapeutics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Frequency Therapeutics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Frequency Therapeutics' net worth. This involves comparing Frequency Therapeutics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Frequency Therapeutics' net worth relative to its peers.
To determine if Frequency Therapeutics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Frequency Therapeutics' net worth research are outlined below:
| Frequency Therapeutics generated a negative expected return over the last 90 days | |
| Frequency Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (81.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Frequency Therapeutics generates negative cash flow from operations | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
Frequency Therapeutics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Frequency Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Frequency Therapeutics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Frequency Therapeutics Target Price Consensus
Frequency target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Frequency Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Frequency analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Frequency stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Frequency Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationFrequency Therapeutics Target Price Projection
Frequency Therapeutics' current and average target prices are 34.12 and 137.76, respectively. The current price of Frequency Therapeutics is the price at which Frequency Therapeutics is currently trading. On the other hand, Frequency Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Frequency Therapeutics Market Quote on 1st of February 2025
Target Price
Analyst Consensus On Frequency Therapeutics Target Price
Follow Frequency Therapeutics' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 320.21 M.Market Cap |
|
Project Frequency Therapeutics' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | (0.38) | (0.40) | |
| Return On Assets | (0.33) | (0.35) | |
| Return On Equity | (0.55) | (0.52) |
When accessing Frequency Therapeutics' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Frequency Therapeutics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Frequency Therapeutics' profitability and make more informed investment decisions.
Evaluate Frequency Therapeutics' management efficiency
Frequency Therapeutics has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7451) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2025, Return On Tangible Assets is likely to drop to -0.35. In addition to that, Return On Capital Employed is likely to drop to -0.4. At this time, Frequency Therapeutics' Non Current Assets Total are very stable compared to the past year. As of the 1st of February 2025, Non Currrent Assets Other is likely to grow to about 2.6 M, while Total Assets are likely to drop about 153.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 127.79 | 134.18 | |
| Tangible Book Value Per Share | 127.79 | 134.18 | |
| Enterprise Value Over EBITDA | 0.64 | 0.68 | |
| Price Book Value Ratio | 0.40 | 0.42 | |
| Enterprise Value Multiple | 0.64 | 0.68 | |
| Price Fair Value | 0.40 | 0.42 |
The strategic initiatives led by Frequency Therapeutics' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Frequency Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Frequency Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Frequency Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Frequency Therapeutics Corporate Filings
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 10th of December 2024 Other Reports | ViewVerify | |
| 6th of December 2024 Other Reports | ViewVerify | |
| 2nd of December 2024 Other Reports | ViewVerify |
Frequency Therapeutics Earnings Estimation Breakdown
The calculation of Frequency Therapeutics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Frequency Therapeutics is estimated to be -2.299275 with the future projection ranging from a low of -2.45 to a high of -1.8975. Please be aware that this consensus of annual earnings estimates for Frequency Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-2.45 Lowest | Expected EPS | -1.9 Highest |
Frequency Therapeutics Earnings Projection Consensus
Suppose the current estimates of Frequency Therapeutics' value are higher than the current market price of the Frequency Therapeutics stock. In this case, investors may conclude that Frequency Therapeutics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Frequency Therapeutics' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 7 | 63.62% | -2.26 | -2.299275 | -9.42 |
Frequency Therapeutics Earnings per Share Projection vs Actual
Actual Earning per Share of Frequency Therapeutics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Frequency Therapeutics predict the company's earnings will be in the future. The higher the earnings per share of Frequency Therapeutics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Frequency Therapeutics Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Frequency Therapeutics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Frequency Therapeutics should always be considered in relation to other companies to make a more educated investment decision.Frequency Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Frequency Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-01 | 2024-09-30 | -2.61 | -2.26 | 0.35 | 13 | ||
2024-08-08 | 2024-06-30 | -2.39 | -2.4287 | -0.0387 | 1 | ||
2024-05-14 | 2024-03-31 | -2.51 | -2.44 | 0.07 | 2 | ||
2024-03-26 | 2023-12-31 | -2.36 | -25.65 | -23.29 | 986 | ||
2023-11-02 | 2023-09-30 | -17.73 | -15.5 | 2.23 | 12 | ||
2023-08-10 | 2023-06-30 | -0.36 | -0.3 | 0.06 | 16 | ||
2023-05-12 | 2023-03-31 | -0.42 | -0.55 | -0.13 | 30 | ||
2023-03-10 | 2022-12-31 | -0.631 | -0.49 | 0.141 | 22 | ||
2022-11-08 | 2022-09-30 | -0.57 | -0.55 | 0.02 | 3 | ||
2022-08-09 | 2022-06-30 | -0.6633 | -0.61 | 0.0533 | 8 | ||
2022-05-04 | 2022-03-31 | -0.6359 | -0.67 | -0.0341 | 5 | ||
2022-03-15 | 2021-12-31 | 0.1527 | -0.62 | -0.7727 | 506 | ||
2021-11-15 | 2021-09-30 | -0.589 | -0.73 | -0.141 | 23 | ||
2021-08-12 | 2021-06-30 | -0.5086 | -0.52 | -0.0114 | 2 | ||
2021-05-13 | 2021-03-31 | 0.1375 | -0.6 | -0.7375 | 536 | ||
2021-03-29 | 2020-12-31 | -0.254 | -0.3 | -0.046 | 18 | ||
2020-11-16 | 2020-09-30 | -0.2775 | -0.16 | 0.1175 | 42 | ||
2020-08-12 | 2020-06-30 | -0.19 | -0.19 | 0.0 | 0 | ||
2020-05-14 | 2020-03-31 | -0.17 | -0.16 | 0.01 | 5 | ||
2020-03-26 | 2019-12-31 | 0.1 | -0.19 | -0.29 | 290 | ||
2019-11-18 | 2019-09-30 | -3.42 | -0.73 | 2.69 | 78 | ||
2019-08-28 | 2019-06-30 | 0 | -6.67 | -6.67 | 0 |
Frequency Therapeutics Corporate Management
| Shelby JD | Senior Counsel | Profile | |
| Vineet MBA | Chief Officer | Profile | |
| Ravi Ramadas | Vice Development | Profile | |
| Steven Colletti | Chief Officer | Profile | |
| Todd MBA | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.